You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage IV non-small cell lung cancer NSCLC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, NSCLC Trial in Tampa (Vorinostat, Pembrolizumab)

Active, not recruiting
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022

Stage IV NSCLC Trial in Dallas (Stereotactic Body Radiation Therapy, Maintenance chemo)

Completed
  • Stage IV Non-Small Cell Lung Cancer
  • Stereotactic Body Radiation Therapy
  • Maintenance chemotherapy
  • Dallas, Texas
    UT Southwestern Medical Center
Jun 30, 2022

NSCLC Trial in Rozzano (Pemetrexed/Carboplatin, Gemcitabine)

Terminated
  • NSCLC
  • Rozzano, Milan, Italy
    Istituto Clinco Humanitas
Sep 8, 2022

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Aldesleukin
  • Pembrolizumab
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Aug 8, 2022

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)

Not yet recruiting
  • Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
  • tereotactic body radiotherapy
  • (no location specified)
Dec 1, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 2, 2023

China With Non-Small-Cell Lung Cancer That is Unable to be

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    May 16, 2023

    Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

    Not yet recruiting
    • Stage IIIB(N2) Non-small Cell Lung Cancer
    • +3 more
    • Pembrolizumab 200 mg IV infusion
    • Beijing, Beijing, China
      Peking University
    May 30, 2023

    Aspirin in Combination With Trametinib and Dabrafenib

    Not yet recruiting
    • NSCLC
    • +4 more
    • Combind asprin with Trametinib and Dabrafenib
    • (no location specified)
    Aug 4, 2023

    NSCLC, NSCLC Stage IV, NSCLC Stage IIIB Trial (MYTX-011)

    Not yet recruiting
    • NSCLC
    • +5 more
    • (no location specified)
    Dec 7, 2022

    Stage IV NSCLC Trial in Wuhan (SBRT+Osimertinib, Osimertinib 80 MG)

    Not yet recruiting
    • Stage IV Non-small Cell Lung Cancer
    • SBRT+Osimertinib
    • Osimertinib 80 MG
    • Wuhan, Hubei, China
      Tongji Hospital Affiliated to Tongji Medical College of Huazhong
    Oct 13, 2022

    Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

    Recruiting
    • Non Small Cell Lung Cancer
    • +16 more
    • Goodyear, Arizona
    • +10 more
    Jan 24, 2023

    NSCLC Stage IV, NSCLC Stage IIIB, NSCLC Stage IIIC Trial in China (Cadonilimab, Anlotinib, Docetaxel)

    Recruiting
    • NSCLC Stage IV
    • +2 more
    • Hefei, Anhui, China
    • +4 more
    Apr 15, 2023

    NSCLC (NSCLC), Stage IV Trial in Switzerland (Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy),

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • Stage IV
    • Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy)
    • +2 more
    • Aarau, Switzerland
    • +7 more
    Oct 27, 2023

    NSCLC (NSCLC) Trial (Sotorasib, Pembrolizumab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • (no location specified)
    Jun 26, 2023

    NSCLC Stage IIIB, NSCLC Stage IIIC, NSCLC Stage IV Trial in Worldwide (Dacomitinib)

    Active, not recruiting
    • NSCLC Stage IIIB
    • +4 more
    • Hong Kong, Hong Kong
    • +8 more
    Jan 10, 2023

    Stage IIIB NSCLC AJCC v7, Stage IV NSCLC AJCC v7 Trial in Portland (Laboratory Biomarker Analysis, Paclitaxel, Pharmacological

    Completed
    • Stage IIIB Non-Small Cell Lung Cancer AJCC v7
    • Stage IV Non-Small Cell Lung Cancer AJCC v7
    • Laboratory Biomarker Analysis
    • +3 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Sep 14, 2022

    NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +5 more
    • Duarte, California
    • +1 more
    Dec 7, 2022

    NSCLC Stage IV Trial (HLX26, Serplulimab, Pemetrexed)

    Not yet recruiting
    • NSCLC Stage IV
    • (no location specified)
    Mar 15, 2023

    EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma Trial in Houston (Poziotinib)

    Recruiting
    • EGFR Exon 20 Mutation
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 12, 2022

    Non Small Cell Lung Cancer Trial in Ostrava (Chemotherapy, Radiotherapy (RT) + Stereotactic Body Ratio Therapy (SBRT),

    Recruiting
    • Non Small Cell Lung Cancer
    • Chemotherapy
    • +2 more
    • Ostrava, Moravian-Silesian Region, Czechia
      University Hospital Ostrava
    Dec 19, 2022

    NSCLC (NSCLC) Trial in Shanghai (Tumor treating fields(EFE-P100), Docetaxel injection)

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • Tumor treating fields（EFE-P100）
    • Docetaxel injection
    • Shanghai, China
      Shanghai Pulmonary Hospital
    Dec 21, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial (Poziotinib

    Not yet recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +3 more
    • Poziotinib Hydrochloride
    • 1429757-68-5, HM781-36B, NOV-1201 Hydrochloride, NOV120101 Hydrochloride, Poziotinib HCl, POZIOTINIB HYDROCHLORIDE
    • (no location specified)
    Jul 18, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

    Active, not recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +5 more
    • Laboratory Biomarker Analysis
    • +3 more
    • New Haven, Connecticut
    • +4 more
    Jan 27, 2023